What does PharmaCom BioVet, Inc. do?

PharmaCom BioVet, Inc. (PHMB) operates in the Medical - Care Facilities industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is PHMB's market cap?

PharmaCom BioVet, Inc. (PHMB) has a market capitalization of approximately $1.1 million, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does PHMB pay a dividend?

No — PharmaCom BioVet, Inc. (PHMB) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

PHMB

PharmaCom BioVet, Inc.

OTC·Medical, Care Facilities · Healthcare

$0.00$0.00+0.00%

Market cap$1.08M·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

+900.00%CAGR +58.50%

Select date range

FromTo

May 5, 1999Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

PHMB does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how PHMB's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PHMB and 80,000+ other tickers.

About PharmaCom BioVet, Inc.

PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds. Established in 1995, the company was previously known as ABV…

CEO: Ira Frohman
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: OTC
Employees: 0
Website: www.pharmacombiovet.com

Peers

Peers Tab

MAHN

Mid-Atlantic Home Health Network, Inc.

Cap

$1.4M

AMBD

American Mobile Dental Corp.

Cap

$85.6K

ARPC

Arem Pacific Corporation

Cap

$336.6K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About PHMB

What does PharmaCom BioVet, Inc. do?: PharmaCom BioVet, Inc. (PHMB) operates in the Medical - Care Facilities industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is PHMB's market cap?: PharmaCom BioVet, Inc. (PHMB) has a market capitalization of approximately $1.1 million, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does PHMB pay a dividend?: No — PharmaCom BioVet, Inc. (PHMB) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.